New hope for advanced breast cancer: experimental drug combo enters human trials

NCT ID NCT07100106

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests a new drug called GDC-4198, alone or combined with another drug (giredestrant), against a standard treatment (abemaciclib plus giredestrant) in people with advanced ER+/HER2- breast cancer that has worsened after prior CDK4/6 inhibitor therapy. The trial has two phases: first to check safety and dosing, then to compare how well the new combination controls the cancer. About 285 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GDC-4198 (also known as RGT-419B) and giredestrant (also known as GDC-9545)
What this could lead to
If successful, this could offer a new treatment option for people with advanced ER+/HER2- breast cancer whose disease has worsened after standard CDK4/6 inhibitor therapy.
What could go wrong
This is an early-phase (Ib/II) trial with only 285 participants, so results may not confirm benefit or safety. The new drug combination might not work better than existing treatments and could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia

    RECRUITING

    Brescia, Lombardy, 25123, Italy

  • Asan Medical Center.

    RECRUITING

    Seoul, 05505, South Korea

  • Barbara Ann Karmanos Cancer Institute

    RECRUITING

    Detroit, Maine, 48201-2013, United States

  • Cancer Research SA

    RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Centre Eugene Marquis

    RECRUITING

    Rennes, 35042, France

  • Centre Francois Baclesse

    RECRUITING

    Caen, 14076, France

  • Centre Oscar Lambret

    RECRUITING

    Lille, 59020, France

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

  • City of Hope - Orange County Lennar Foundation Cancer Center

    RECRUITING

    Irvine, California, 92618, United States

  • City of Hope® Cancer Center Chicago

    RECRUITING

    Zion, Illinois, 60099, United States

  • Fudan University Shanghai Cancer Center - Pudong Campus

    RECRUITING

    Shanghai, Shanghai Municipality, 201321, China

  • Gangnam Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 6273, South Korea

  • Gustave Roussy

    RECRUITING

    Villejuif, Val-de-Marne, 94805, France

  • Hospital Beata Maria Ana

    RECRUITING

    Madrid, 28007, Spain

  • Hospital Clinico Universitario de Valencia

    RECRUITING

    Valencia, 46010, Spain

  • Hospital General Universitario Gregorio Maranon

    RECRUITING

    Madrid, 28007, Spain

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital de Clinicas de Porto Alegre (HCPA) - PPDS

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90560-030, Brazil

  • Hospital do Cancer de Pernambuco - HCP

    RECRUITING

    Recife, Pernambuco, 50040-000, Brazil

  • IRCCS Azienda Ospedaliero Universitaria di Bologna

    RECRUITING

    Bologna, Emilia-Romagna, 40138, Italy

  • Institut Jean Godinot

    RECRUITING

    Reims, Champagne-Ardenne, 51100, France

  • Instituto Do Câncer Do Estado de São Paulo Octávio Frias de Oliveira - ICESP

    RECRUITING

    São Paulo, 01246-000, Brazil

  • Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON

    RECRUITING

    Barcelona, 08035, Spain

  • Irmandade Da Santa Casa de Misericordia de Porto Alegre

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90035-074, Brazil

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l - PPDS

    RECRUITING

    Meldola, Emilia-Romagna, 47014, Italy

  • KEM - Evang. Huyssens-Stiftung Essen-Huttrop

    RECRUITING

    Essen, North Rhine-Westphalia, 45136, Germany

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Maryland Oncology Hematology - Annapolis

    RECRUITING

    Annapolis, Maryland, 21401, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • Montefiore Einstein Cancer Center

    RECRUITING

    The Bronx, New York, 10461, United States

  • New York Cancer & Blood Specialists

    RECRUITING

    East Patchogue, New York, 11772, United States

  • Novant Health Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • ONCOSITE Centro de Pesquisa Clínica Em Oncologia

    RECRUITING

    Ijuí, Rio Grande do Sul, 98700-000, Brazil

  • Oncology Associates of Oregon, P.C

    RECRUITING

    Eugene, Oregon, 97401, United States

  • Ospedale San Raffaele S.r.l. - PPDS

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Penn State Health Milton S. Hershey Medical Center

    RECRUITING

    Hershey, Pennsylvania, 17033-2360, United States

  • Princess Margaret Hospital

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Rutgers Cancer Institute of New Jersey

    RECRUITING

    New Brunswick, New Jersey, 08901-1914, United States

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, 13620, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 3722, South Korea

  • Shandong Cancer Hospital

    RECRUITING

    Jinan, SD, 250117, China

  • St Vincent's Hospital Sydney

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

  • Sylvester Comprehensive Cancer Center

    RECRUITING

    Miami, Florida, 33136-1002, United States

  • Texas Oncology (Worth) - USOR

    RECRUITING

    Dallas, Texas, 75246-2003, United States

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, 6591, South Korea

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300060, China

  • UC San Diego Moores Cancer Center

    RECRUITING

    La Jolla, California, 92093-1503, United States

  • UCSF Helen Diller Family CCC

    RECRUITING

    San Francisco, California, 94158, United States

  • UPMC - Hillman Cancer Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15213-3108, United States

  • Universitatsklinikum Hamburg-Eppendorf

    RECRUITING

    Hamburg, 20251, Germany

  • Universitatsklinikum Tubingen

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • University of Arizona Cancer Center

    RECRUITING

    Tucson, Arizona, 85724-0001, United States

  • University of California San Diego Medical Center

    RECRUITING

    San Diego, California, 92103-1911, United States

  • University of Pennsylvania - Abramson Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • University of Utah Huntsman Cancer Institute

    RECRUITING

    Salt Lake City, Utah, 84013, United States

  • Vanderbilt Breast Center at One Hundred Oaks

    RECRUITING

    Nashville, Tennessee, 37204-3609, United States

  • Virginia Oncology Associates (Norfolk) - USOR

    RECRUITING

    Norfolk, Virginia, 23502-2800, United States

  • Washington University Siteman Cancer Center

    RECRUITING

    St Louis, Missouri, 63110-1010, United States

  • Winship Cancer Institute of Emory University

    RECRUITING

    Atlanta, Georgia, 30322-1013, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.